Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a year after diagnosis.
Experimental drug shows survival benefit in pancreatic cancer trial
- Post author:admin
- Post published:April 14, 2026
- Post category:uncategorized